270 related articles for article (PubMed ID: 11356842)
1. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
[TBL] [Abstract][Full Text] [Related]
2. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
[TBL] [Abstract][Full Text] [Related]
3. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
Guo C; Whitmarsh AJ
J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
[TBL] [Abstract][Full Text] [Related]
4. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
[TBL] [Abstract][Full Text] [Related]
5. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.
Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ
J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664
[TBL] [Abstract][Full Text] [Related]
6. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus.
Wang P; Wu Y; Ge X; Ma L; Pei G
J Biol Chem; 2003 Mar; 278(13):11648-53. PubMed ID: 12538596
[TBL] [Abstract][Full Text] [Related]
8. Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway.
Pan J; Li H; Zhang B; Xiong R; Zhang Y; Kang WY; Chen W; Zhao ZB; Chen SD
PLoS One; 2015; 10(4):e0119204. PubMed ID: 25856433
[TBL] [Abstract][Full Text] [Related]
9. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
Seo J; Tsakem EL; Breitman M; Gurevich VV
J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
[TBL] [Abstract][Full Text] [Related]
10. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
Kobayashi H; Narita Y; Nishida M; Kurose H
Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Dvl-1/β-arrestin2/JNK3 interaction disrupts Wnt5a-JNK3 signaling and protects hippocampal CA1 neurons during cerebral ischemia reperfusion.
Wei X; Gong J; Ma J; Zhang T; Li Y; Lan T; Guo P; Qi S
Neuropharmacology; 2018 Jun; 135():11-21. PubMed ID: 29510185
[TBL] [Abstract][Full Text] [Related]
12. How does arrestin assemble MAPKs into a signaling complex?
Song X; Coffa S; Fu H; Gurevich VV
J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
[TBL] [Abstract][Full Text] [Related]
13. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
Scott MG; Le Rouzic E; Périanin A; Pierotti V; Enslen H; Benichou S; Marullo S; Benmerah A
J Biol Chem; 2002 Oct; 277(40):37693-701. PubMed ID: 12167659
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10.
Neidhart S; Antonsson B; Gilliéron C; Vilbois F; Grenningloh G; Arkinstall S
FEBS Lett; 2001 Nov; 508(2):259-64. PubMed ID: 11718727
[TBL] [Abstract][Full Text] [Related]
15. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.
Tóth AD; Prokop S; Gyombolai P; Várnai P; Balla A; Gurevich VV; Hunyady L; Turu G
J Biol Chem; 2018 Jan; 293(3):876-892. PubMed ID: 29146594
[TBL] [Abstract][Full Text] [Related]
16. N-terminal tyrosine modulation of the endocytic adaptor function of the beta-arrestins.
Marion S; Fralish GB; Laporte S; Caron MG; Barak LS
J Biol Chem; 2007 Jun; 282(26):18937-44. PubMed ID: 17456469
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
Willoughby EA; Collins MK
J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
[TBL] [Abstract][Full Text] [Related]
18. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
Miller WE; Maudsley S; Ahn S; Khan KD; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2000 Apr; 275(15):11312-9. PubMed ID: 10753943
[TBL] [Abstract][Full Text] [Related]
19. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
20. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
